Trade Mark Journal No.2021/053 31 December 2021

WO0000001630643 (35,42)

Office of origin: United States of America

Date of International Registration:30 September 2021
Date of designation in the UK: 30 September 2021
Image for mark 1630643

The mark consists of the stylized interlocked lettering "PF" in which the letter "P" is grey and the letter "F" is blue. A gold triangle design is positioned below the stylized lettering "PF". The stylized wording and design, as illustrated in the mark, are positioned on top of a white rectangular background, which is not a claimed feature of the mark.

The mark contains the colours grey, blue and gold.

The mark consists of the stylized interlocked lettering "PF" in which the letter "P" is grey and the letter "F" is blue. A gold triangle design is positioned below the stylized lettering "PF". The stylized wording and design, as illustrated in the mark, are positioned on top of a white rectangular background, which is not a claimed feature of the mark.

Class 35
Business consulting, business management consultation, and business project management services in the field of designing, building, testing, and validating facilities, equipment, processes, and systems for use by pharmaceutical, bio-pharmaceutical, gene and cell therapy, healthcare, and medical device companies, and contract research and contract manufacturing organizations, all of the foregoing excluding the development and manufacture of pharmaceutical products and excluding the providing of health care services.
Class 42
Engineering services in the field of designing and building facilities and equipment for use by pharmaceutical, bio-pharmaceutical, gene and cell therapy, healthcare, and medical device companies, and contract research and contract manufacturing organizations; scientific consulting and computer project management services in the fields of designing and procuring production systems and equipment for use by pharmaceutical, bio-pharmaceutical, gene and cell therapy, healthcare, and medical device companies, and contract research and contract manufacturing organizations, for the purpose of manufacturing pharmaceuticals and medical devices; scientific consulting and computer project management services in the fields of quality management, compliance testing, commissioning, and validation of manufacturing facilities, manufacturing processes, clinical processes, systems automation, and laboratory and facility safety, provided to pharmaceutical, bio-pharmaceutical, gene and cell therapy, healthcare, and medical device companies, and contract research and contract manufacturing organizations, to assist them in complying with certification standards, health laws and health regulations; all of the foregoing excluding the development and manufacture of pharmaceutical products and excluding the providing of health care services.

Precision Medicine Group, LLC

Representative: Donna H. Hartman OLENDERFELDMAN LLP, 422 Morris Avenue, Summit NJ 07901, UNITED STATES OF AMERICA